KR20240011144A - 항원-결합 단백질의 조작 - Google Patents

항원-결합 단백질의 조작 Download PDF

Info

Publication number
KR20240011144A
KR20240011144A KR1020237039964A KR20237039964A KR20240011144A KR 20240011144 A KR20240011144 A KR 20240011144A KR 1020237039964 A KR1020237039964 A KR 1020237039964A KR 20237039964 A KR20237039964 A KR 20237039964A KR 20240011144 A KR20240011144 A KR 20240011144A
Authority
KR
South Korea
Prior art keywords
sequence
chain
sequences
training
chain sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237039964A
Other languages
English (en)
Korean (ko)
Inventor
진우 림
제이콥 갈슨
Original Assignee
알케맙 테라퓨틱스 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알케맙 테라퓨틱스 엘티디 filed Critical 알케맙 테라퓨틱스 엘티디
Publication of KR20240011144A publication Critical patent/KR20240011144A/ko
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/044—Recurrent networks, e.g. Hopfield networks
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/045—Combinations of networks
    • G06N3/0455—Auto-encoder networks; Encoder-decoder networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/10—Design of libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Molecular Biology (AREA)
  • Library & Information Science (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Computing Systems (AREA)
  • General Physics & Mathematics (AREA)
  • Computational Linguistics (AREA)
  • Mathematical Physics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020237039964A 2021-04-22 2022-04-14 항원-결합 단백질의 조작 Pending KR20240011144A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2105776.5A GB202105776D0 (en) 2021-04-22 2021-04-22 Engineering of antigen-binding proteins
GB2105776.5 2021-04-22
PCT/EP2022/060073 WO2022223451A1 (en) 2021-04-22 2022-04-14 Engineering of antigen-binding proteins

Publications (1)

Publication Number Publication Date
KR20240011144A true KR20240011144A (ko) 2024-01-25

Family

ID=76193388

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237039964A Pending KR20240011144A (ko) 2021-04-22 2022-04-14 항원-결합 단백질의 조작

Country Status (10)

Country Link
US (1) US20240203523A1 (https=)
EP (1) EP4327328A1 (https=)
JP (1) JP2024514691A (https=)
KR (1) KR20240011144A (https=)
CN (1) CN117337470A (https=)
AU (1) AU2022260043A1 (https=)
CA (1) CA3215778A1 (https=)
GB (1) GB202105776D0 (https=)
IL (1) IL307832A (https=)
WO (1) WO2022223451A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113392929B (zh) * 2021-07-01 2024-05-14 中国科学院深圳先进技术研究院 一种基于词嵌入与自编码器融合的生物序列特征提取方法
IL321771A (en) 2023-01-09 2025-08-01 Lilly Co Eli Anti-unc5c antibodies
EP4688852A2 (en) 2023-04-03 2026-02-11 Alchemab Therapeutics Ltd. Anti-cd33 antibodies
WO2025022002A1 (en) 2023-07-26 2025-01-30 Alchemab Therapeutics Ltd Analysis of antigen-binding proteins
US20250079011A1 (en) * 2023-09-01 2025-03-06 Siemens Healthcare Diagnostics Inc. Clinical decision support using transformer-based networks by imputing biomarkers
WO2025125898A1 (en) 2023-12-15 2025-06-19 Alchemab Therapeutics Ltd Anti-unc5c antibodies and uses thereof
US12367329B1 (en) * 2024-06-06 2025-07-22 EvolutionaryScale, PBC Protein binder search

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7648099B2 (ja) * 2019-05-19 2025-03-18 ジャスト－エヴォテック バイオロジクス，インコーポレイテッド 機械学習法によるタンパク質配列の生成

Also Published As

Publication number Publication date
JP2024514691A (ja) 2024-04-02
CN117337470A (zh) 2024-01-02
CA3215778A1 (en) 2022-10-27
WO2022223451A1 (en) 2022-10-27
US20240203523A1 (en) 2024-06-20
EP4327328A1 (en) 2024-02-28
GB202105776D0 (en) 2021-06-09
IL307832A (en) 2023-12-01
AU2022260043A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
KR20240011144A (ko) 항원-결합 단백질의 조작
Shuai et al. Generative language modeling for antibody design
Steichen et al. A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
Friedensohn et al. Convergent selection in antibody repertoires is revealed by deep learning
Sirupurapu et al. Gene prediction in the immunoglobulin loci
WO2025022002A1 (en) Analysis of antigen-binding proteins
Wu et al. Fast and accurate modeling and design of antibody-antigen complex using tFold
Khass et al. VpreB serves as an invariant surrogate antigen for selecting immunoglobulin antigen-binding sites
Xu et al. Advances in antibody discovery from human BCR repertoires
JP2025536256A (ja) 抗原結合性タンパク質の工学操作
Ramon et al. Deep learning assessment of nativeness and pairing likelihood for antibody and nanobody design with AbNatiV2
Cohen et al. NanoNet: Rapid end-to-end nanobody modeling by deep learning at sub angstrom resolution
Ali et al. Improving nanobody structure prediction with self-distillation
Campbell et al. Combining random mutagenesis, structure-guided design and next-generation sequencing to mitigate polyreactivity of an anti-IL-21R antibody
Ramon et al. AbNatiV: VQ-VAE-based assessment of antibody and nanobody nativeness for hit selection, humanisation, and engineering
Zeglinski et al. alpseq: an open-source workflow to turbocharge nanobody discovery with high-throughput sequencing
Zou et al. Antibody humanization via protein language model and neighbor retrieval
Zhao et al. Quantitative characterization of the B cell receptor repertoires of human immunized with commercial rabies virus vaccine
Jiang et al. Comprehensive assembly of monoclonal and mixed antibody sequences
Jarasch et al. Aligning, analyzing, and visualizing sequences for antibody engineering: Automated recognition of immunoglobulin variable region features
Ali et al. Disulphide and sequence-encoded conformational priors guide nanobody structure prediction
Mitchell Advancing hybridoma sequencing, dissemination, and antibody validation with novel
Olsen Investigating B-cell repertoire data using deep learning approaches to aid in the development of antibody therapeutics
Gueto-Tettay et al. Cumulating MS Signal enables polyclonal antibody analysis
Fujiwara et al. De novo design of therapeutic scFvs and multi-specific engagers from sequence alone

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231121

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250411

Comment text: Request for Examination of Application